Bro S, Bjorner J B, Tofte-Jensen P, Klem S, Almtoft B, Danielsen H, Meincke M, Friedberg M, Feldt-Rasmussen B
Department of Nephrology, Rigshospitalet, Copenhagen, Denmark.
Perit Dial Int. 1999 Nov-Dec;19(6):526-33.
The goals for maintenance dialysis treatment are to improve patient survival, reduce patient morbidity, and improve patient quality of life. This is the first randomized prospective study comparing automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) treatment with respect to quality of life and clinical outcomes in relation to therapy costs.
A prospective, randomized multicenter study.
Three Danish CAPD units.
Thirty-four adequately dialyzed patients with high or high-average peritoneal transport characteristics were included in the study.Twenty-five patients completed the study.
After randomization, 17 patients were allocated to APD treatment and 17 patients to CAPD treatment for a period of 6 months. Medical and biochemical parameters were evaluated at monthly controls in the CAPD units. Quality-of-life parameters were assessed at baseline and after 6 months by the self-administered short-form SF-36 generic health survey questionnaire supplemented with disease- and treatment-specific questions. Therapy costs were compared by evaluating dialysis-related expenses.
Quality-of-life parameters, dialysis-related complications, dialysis-related expenses.
The quality-of-life studies showed that significantly more time for work, family, and social activities was available to patients on APD compared to those on CAPD (p < 0.001). Although the difference was not significant, there was a tendency for less physical and emotional discomfort caused by dialysis fluid in the APD group. Sleep problems, on the other hand, tended to be more marked in the APD group. Any positive effect of APD compared to CAPD on dialysis-related hospital days or complication rates could not be confirmed. With larger patient samples, it is possible, however, that a significant difference might have been achieved. The running costs for APD treatment were US $75 per day and for CAPD treatment US $61 per day.
If APD treatment can help to keep selected patients vocationally or socially active, paying the extra cost seems reasonable.
维持性透析治疗的目标是提高患者生存率、降低患者发病率并改善患者生活质量。这是第一项关于自动腹膜透析(APD)和持续非卧床腹膜透析(CAPD)在生活质量以及与治疗费用相关的临床结局方面进行比较的随机前瞻性研究。
一项前瞻性、随机多中心研究。
丹麦的三个CAPD单位。
34例腹膜转运特性为高或高平均水平且透析充分的患者纳入研究。25例患者完成了研究。
随机分组后,17例患者接受APD治疗,17例患者接受CAPD治疗,为期6个月。在CAPD单位每月进行检查时评估医学和生化参数。在基线时以及6个月后,通过自行填写的简短型SF - 36通用健康调查问卷并补充疾病及治疗特定问题来评估生活质量参数。通过评估透析相关费用来比较治疗费用。
生活质量参数;透析相关并发症;透析相关费用。
生活质量研究表明,与接受CAPD治疗的患者相比,接受APD治疗的患者有更多时间用于工作、家庭和社交活动(p < 0.001)。虽然差异不显著,但APD组中透析液引起的身体和情绪不适有减少的趋势。另一方面,睡眠问题在APD组中往往更明显。与CAPD相比,APD对透析相关住院天数或并发症发生率的任何积极影响均未得到证实。然而,如果样本量更大,有可能会得出显著差异。APD治疗的每日运行成本为75美元,CAPD治疗为每日61美元。
如果APD治疗有助于使特定患者保持职业或社交活动,那么支付额外费用似乎是合理的。